Form 4: ReposiTrak CEO Sells Shares for Charitable Commitments

Sentiment:

Insider Transaction Report


ReposiTrak CEO Randall K. Fields sold 7,500 shares of common stock for charitable commitments through a Rule 10b5-1 plan.

Summary

  • Randall K. Fields, Chief Executive Officer, Director, and 10% Owner of ReposiTrak, Inc., reported a sale of 7,500 shares of common stock.
  • The transaction occurred on October 20, 2025, at a weighted average price of $15.467 per share, with individual sales ranging from $14.80 to $15.21.
  • The sale was executed automatically pursuant to a Rule 10b5-1 trading plan, which was adopted by Mr. Fields in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC.
  • The trading plan was established to enable Mr. Fields to meet some of his charitable commitments.
  • Following the transaction, Mr. Fields' beneficial ownership includes 3,683,955 shares of Common Stock held directly.
  • Indirect beneficial ownership of Common Stock includes 35,000 shares by RK Fields Charitable 2022, LLC, 615,260 shares by Riverview Financial Corp., 30,667 shares by Spouse, and 333,643 shares by Fields Management, Inc.
  • Indirect beneficial ownership of Series B Preferred Stock includes 289,673 shares by Riverview Financial Corp and 6,721 shares by Spouse.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While it's an insider sale, which can sometimes be viewed negatively, the transaction was pre-planned under a 10b5-1 plan and explicitly stated to be for charitable commitments, mitigating potential negative interpretations.

Negatives

  • Insider selling, even when pre-planned and for charitable reasons, can sometimes be perceived by the market as a slight negative signal regarding future company prospects or management's confidence.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Management Comments

  • The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in his capacity as Trustee of the 2022 RK Fields Charitable Remainder Unitrust, the managing member of RK Fields Charitable 2022, LLC.
  • The Trading Plan was established to enable the Reporting Person to meet some of his charitable commitments.

Industry Context

This insider transaction report is specific to ReposiTrak, Inc. and does not provide broader industry context or trends.

Related Party Transactions

  • The sale was conducted by RK Fields Charitable 2022, LLC, an entity associated with the reporting person, Randall K. Fields.

Stakeholder Impact

  • Shareholders: The sale of shares by a key executive and 10% owner could lead to minor shifts in market sentiment, although the pre-planned nature and charitable intent may temper any significant impact.

Key Dates

DateDescription
10/20/2025Date of transaction (sale of common stock)
10/21/2025Date the Form 4 was signed and filed

Recommendation

hold

A single insider sale, particularly one executed under a Rule 10b5-1 plan for charitable purposes, typically does not provide sufficient new information to warrant a change in a seasoned investor's fundamental investment thesis. The transaction is pre-scheduled and for a specific personal reason, not necessarily indicative of management's view on the company's immediate future performance. Therefore, a 'hold' recommendation is appropriate, suggesting no immediate action based solely on this filing.

Keywords

ReposiTrak, TRAK, Randall K. Fields, Insider Trading, Form 4, Stock Sale, CEO, 10b5-1 Plan, Charitable Commitments

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.